✨
AI Summary
- Shelby Newsad transitioned from pre-med to biotech investing.
- Commercialization is key to translating research into impact.
- Compound VC focuses on thesis-driven, research-centric investments.
Guests on This Episode
SN
Shelby Newsad
1 podcast appearance
More from Nucleate Podcast
